Shanghai-OPKO Signs Vaccine Technology Agreement With Taiwan's Academia Sinica
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Shanghai-OPKO Health has signed an exclusive, worldwide licensing agreement on a novel vaccine technology developed by Taiwan's Academia Sinica